Four faculty members were honored with chancellor’s medals, and seven others were invested as named professors at the annual Convocation and Investiture celebration.

Festivities kick off on Friday, Sept. 6, with the T.H. Chan School of Medicine White Coat Ceremony, welcoming the new class of medical students into the medical community.

These highly accomplished faculty members have been appointed to endowed chairs at UMass Chan Medical School: Dale L. Greiner, PhD; Danny G. Winder, PhD; Elinor K. Karlsson, PhD; Jeannette M. Wolfe, MD; J. Kevin Donahue, MD; and John E. Harris, MD, PhD’05.

The BRIDGE Fund supports critical research milestones for inventions and discoveries that have high potential to change the course of disease and continues to grow, increasing from approximately $1 million per year in 2019 to $3 million in 2024.

John E. Harris, MD, PhD, and Manuel Garber, PhD, will lead a $3.75 million NIH clinical study at UMass Chan Medical School to identify potential preclinical genetic, molecular and biological signatures that may predispose patients to developing vitiligo.

Craig Ceol, PhD, has received a grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to fund research on cellular and molecular regulators of melanocyte regeneration using zebrafish as a model.

The UMass Cancer Center Pilot Project Program has awarded seed grants to five UMass Chan Medical School research projects to enable investigators to gather pilot data for external cancer-focused funding.

John Harris, MD, PhD, one of the nation’s foremost authorities on the treatment and study of vitiligo, has been appointed chair of the Department of Dermatology beginning Jan. 1.

John E. Harris, MD, PhD, has been named a recipient of the Presidential Early Career Award for Scientists and Engineers, the highest honor bestowed by the U.S. government to outstanding scientists and engineers who are beginning their independent research careers.

John E. Harris, MD, PhD, and colleagues have made a promising discovery that could lead to therapies for vitiligo with longer-lasting effects, according to new research published in Science Translational Medicine on July 18.

John E. Harris, MD, PhD, and colleagues have made a promising discovery that could lead to therapies for vitiligo with longer-lasting effects, according to new research published in Science Translational Medicine on July 18.

UMass Medical School vitiligo expert John Harris, MD, PhD, raised awareness and addressed misconceptions about the skin condition vitiligo in an interview with Mallika Marshall of WBZ-TV.

In an essay published by The Conversation, John Harris, MD, talks about his lab's vitiligo research and possible new therapeutics that could be longer lasting----possibly even permanent----than current treatments available.

As UMass Medical School prepares to host the World Vitiligo Day Conference from June 22 to 24, John Harris, MD, PhD, director of the Vitiligo Clinic and Research Center, explained the common skin condition in a FaceBook Live interview.

John Harris MD, PhD, has dedicated his research to better understanding what causes vitiligo, an autoimmune disease that results in the appearance of white spots on the skin, according to an article in the Worcester Telegram & Gazette.